DeepMed Research

insulin

Generic Name: insulin

Clinical Trials

GDM: Insulin with or Without Metformin?

Phase 4

Recruiting

Conditions: Gestational Diabetes

Interventions: Drug: Metformin + Insulin
Drug: Insulin

First Posted Date: 2025-01-17

Last Posted Date: 2025-01-17

Lead Sponsor: University of Virginia

Target Recruit Count: 130

Registration Number: NCT06781775

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Phase 2

Recruiting

Conditions: Diabetes

Interventions: Drug: Insulin
Drug: Semaglutide
Drug: Empagliflozin

First Posted Date: 2025-01-07

Last Posted Date: 2025-02-25

Lead Sponsor: Mostafa Bahaa

Target Recruit Count: 105

Registration Number: NCT06762314

Locations: 🇪🇬
Tanta Unuversity, Tanta, Egypt

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

Phase 4

Recruiting

Conditions: Ketosis Prone Diabetes

Interventions: Device: Continuous Glucose Monitoring
Drug: Insulin

First Posted Date: 2024-11-21

Last Posted Date: 2025-01-27

Lead Sponsor: Emory University

Target Recruit Count: 12

Registration Number: NCT06699810

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus

Phase 3

Recruiting

Conditions: Keratoconus
Cornea Disease
Eye Diseases
Wound Heal

Interventions: Drug: Insulin
Drug: Placebo eye drops of 0.5% Methylcellulose

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-14

Lead Sponsor: University of Campinas, Brazil

Target Recruit Count: 36

Registration Number: NCT06601101

Locations: 🇧🇷
State University of Campinas, Campinas, São Paulo, Brazil

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Phase 4

Recruiting

Conditions: Pregnancy, High Risk
Gestational Diabetes Mellitus

Interventions: Drug: Insulin
Drug: Metformin

First Posted Date: 2024-06-06

Last Posted Date: 2025-05-08

Lead Sponsor: Ohio State University

Target Recruit Count: 1572

Registration Number: NCT06445946

Locations: 🇺🇸
Eastern Virginia Medical School - Old Dominion University, Norfolk, Virginia, United States
🇺🇸
University of Alabama, Tuscaloosa, Alabama, United States
🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States

and more 17 locations

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)

Not Applicable

Recruiting

Conditions: Gestational Diabetes
Pregnancy Related

Interventions: Drug: Insulin

First Posted Date: 2024-05-17

Last Posted Date: 2024-11-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 430

Registration Number: NCT06419803

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

Not Applicable

Recruiting

Conditions: Gestational Diabetes
Pregnancy Related

Interventions: Drug: Insulin

First Posted Date: 2024-05-17

Last Posted Date: 2024-11-21

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 430

Registration Number: NCT06419777

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Topical Insulin for Postoperative Wound Healing

Not Applicable

Active, not recruiting

Conditions: Wound Complication
Insulin Resistance, Diabetes

Interventions: Drug: Insulin
Drug: Povidone-Iodine

First Posted Date: 2024-05-06

Last Posted Date: 2024-08-21

Lead Sponsor: Cairo University

Target Recruit Count: 74

Registration Number: NCT06400082

Locations: 🇪🇬
Omnia Azmy Nabeh, Cairo, Egypt

Regional Lipolysis Insulin Regulation

Early Phase 1

Recruiting

Conditions: Obesity

Interventions: Drug: Insulin

First Posted Date: 2024-05-01

Last Posted Date: 2025-04-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 48

Registration Number: NCT06392854

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study

Not Applicable

Withdrawn

Conditions: Alzheimer Disease
Mild Cognitive Impairment

Interventions: Drug: Insulin
Drug: Placebo

First Posted Date: 2024-04-30

Last Posted Date: 2025-01-27

Lead Sponsor: Erasme University Hospital

Target Recruit Count: 120

Registration Number: NCT06391853

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy